NEW YORK (Reuters Health) – Hypoallergenic infantformulas may help lower the long-term risk of allergies in childrenwho are genetically vulnerable to them, a new study suggests.

The products, known as hydrolyzed infant formulas, are designedto lower the likelihood of the allergic responses some infants haveto standard formula.

Like standard formula, hydrolyzed products contain cow’s milkproteins; the difference is that the proteins are broken down sothat they are less allergenic than the whole proteins in regularformula.

Studies have shown that compared with regular formula,hydrolyzed versions seem to lower the risk of allergies in infancyand early childhood. The new findings suggest that those benefitslast at least until the age of 6.

social poster